Quantitative molecular analysis of virus expression and replication

Journal of Clinical Microbiology

Volumn 38, Issue 6, 2000, Pages 2030-2036

  Clementi, Massimo ^a  

^a UNIVERSITY OF TRIESTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

NUCLEIC ACID;

ANALYTIC METHOD; GENE AMPLIFICATION; NONHUMAN; NUCLEIC ACID ANALYSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ASSAY; SHORT SURVEY; VIRAL GENETICS; VIRUS DIAGNOSIS; VIRUS EXPRESSION; VIRUS REPLICATION; VIRUS TRANSCRIPTION;

ANIMALIA; DNA VIRUSES;

EID: 0034043495     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.38.6.2030-2036.2000     Document Type: Short Survey

References (102)

1. Bagnarelli, P., C. Balotta, A. Valenza, F. Mazzola, M. C. Colombo, M. Violin, M. Galli, and M. Clementi. 1997. Patterns of HIV-1 transcripts in peripheral blood lymphocytes from long-term nonprogressors and typical progressor patients. J. Acquir. Immune Defic. Syndr. 15(Suppl. I):S69-S71.
2. Bagnarelli, P., M. Candela, A. Valenza, A. Manzin, L. Solforosi, F. Mazzola, L. Butini, M. Montroni, A. Gabrielli, P. E. Varaldo, and M. Clementi. 1996. Dynamic features of human immunodeficiency virus type 1 (HIV-1) viremia: kinetics of cell-free HIV RNA after therapeutic plasma exchange. J. Infect. Dis. 176:801-804.
3. Bagnarelli, P., S. Menzo, A. Valenza, A. Manzin, M. Giacca, F. Ancarani, G. Scalise, P. E. Varaldo, and M. Clementi. 1992. Molecular profile of human immunodeficiency virus type 1 infection in symptomless patients and in patients with AIDS. J. Virol. 66:7328-7335.
4. Bagnarelli, P., S. Menzo, A. Valenza, S. Paolucci, S. Petroni, G. Scalise, R. Sampaolesi, A. Manzin, P. E. Varaldo, and M. Clementi. 1995. Quantitative molecular monitoring of human immunodeficiency virus type 1 activity during therapy with specific antiretroviral compounds. J. Clin. Microbiol. 33:16-23.
5. Bagnarelli, P., A. Valenza, S. Menzo, A. Manzin, G. Scalise, P. E. Varaldo, and M. Clementi. 1994. Dynamics of molecular parameters of human immunodeficiency virus type 1 activity in vivo. J. Virol. 68:2495-2502.
6. Bagnarelli, P., A. Valenza, S. Menzo, R. Sampaolesi, P. E. Varaldo, L. Butini, M. Montroni, C.-F. Perno, S. Aquaro, D. Mathez, J. Leibowitch, C. Balotta, and M. Clementi. 1996. Dynamics and modulation of human immunodeficiency virus type 1 transcripts in vitro and in vivo. J. Virol. 70: 7603-7613.
7. Ballardini, G., A. Manzin, F. Giostra, R. Francesconi, P. Groff, A. Grassi, L. Solforosi, S. Ghetti, D. Zauli, M. Clementi, and F. B. Bianchi. 1997. Quantitative liver parameters of HCV infection: relation to HCV genotypes, viremia, and response to interferon treatment. J. Hepatol. 26:779-786.
8. Barany, F. 1991. Genetic disease detection and DNA amplification using cloned thermostable ligase. Proc. Natl. Acad. Sci. USA 88:189-193.
9. Bell, J. I. 1999. Clinical research is dead: long live clinical research. Nat. Med. 5:477-478.
10. Berger, A., J. Braner, H. W. Doerr, and B. Weber. 1998. Quantification of viral load: clinical relevance for human immunodeficiency virus, hepatitis B virus and hepatitis C virus infection. Intervirology 41:24-34.
11. Boeckh, M., and G. Boivin. 1998. Quantitation of cytomegalovirus: methodologic aspects and clinical applications. Clin. Microbiol. Rev. 11:533-554.
12. Boivin, G., J. Handfield, E. Toma, R. Lalonde, and M. G. Bergeron. 1999. Expression of the late cytomegalovirus (CMV) pp150 transcript in leukocytes of AIDS patients is associated with high viral DNA load in leukocytes and presence of CMV DNA in plasma. J. Infect. Dis. 179:1101-1107.
13. Boivin, G., C. A. Olson, M. R. Quirk, B. Kringstad, M. I. Hertz, and M. C. Jordan. 1996. Quantitation of cytomegalovirus DNA and characterization of viral gene expression in bronchoalveolar cells of infected patients with or without pneumonitis. J. Infect. Dis. 173:1304-1312.
14. Bonhoeffer, S., R. M. May, G. M. Shaw, and M. A. Nowak. 1997. Virus dynamics and drug therapy. Proc. Natl. Acad. Sci. USA 94:6971-6976.
15. Bouffard, P., P. H. Hayashi, R. Acevedo, M. Levy, and J. B. Zeldis. 1992. Hepatitis C virus infection is detected in a monocyte/macrophage subpopulation of peripheral blood mononuclear cells of infected patients. J. Infect. Dis. 166:1276-1280.
16. Bowen, E. F., C. A. Sabin, P. Wilson, P. D. Griffiths, C. C. Davey, M. A. Johnson, and V. C. Emery. 1997. Cytomegalovirus (CMV) viraemia detected by polymerase chain reaction identifies a group of HIV-positive patients at high risk of CMV disease. AIDS 11:889-893.
17. Cao, Y., L. Qin, L. Zhang, J. Safrit, and D. D. Ho. 1995. Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection. N. Engl. J. Med. 332:201-208.
18. Clementi, M., P. Bagnarelli, S. Menzo, A. Valenza, A. Manzin, and P. E. Varaldo. 1993. Clearance of HIV viremia after seroconversion. Lancet 341:315-316.
19. Clementi, M., P. Bagnarelli, A. Manzin, and S. Menzo. 1994. Competitive polymerase chain reaction and analysis of viral activity at the molecular level. Genet. Anal. Tech. Appl. 11:1-6.
20. Clementi, M., S. Menzo, P. Bagnarelli, A. Manzin, A. Valenza, and P. E. Varaldo. 1993. Quantitative PCR and RT-PCR in virology. PCR Methods Appl. (CSH) 2:191-196.
21. Clementi, M., S. Menzo, P. Bagnarelli, A. Valenza, S. Paolucci, R. Sampaolesi, A. Manzin, and P. E. Varaldo. 1996. Clinical use of quantitative molecular methods in studying human immunodeficiency virus type 1 infection. Clin. Microbiol. Rev. 9:135-147.
22. Collier, J. D., B. Zanke, M. Moore, G. Kessler, M. Krajden, F. Shepherd, and J. Heathcote. 1999. No association between hepatitis C and B-cell lymphoma. Hepatology 29:1259-1261.
23. Comar, M., G. Marzio, P. D'Agaro, and M. Giacca. 1996. Quantitative dynamics of HIV type 1 expression. AIDS Res. Hum. Retrovir. 12:117-126.
24. Dammacco, F., P. Gatti, and D. Sansonno. 1998. Hepatitis C virus infection, mixed cryoglobulinemia, and non-Hodgkin's lymphoma: an emerging picture. Leuk. Lymphoma 31:463-476.
25. Fanning, L., E. Kenny, M. Sheehan, B. Cannon, M. Whelton, J. O'Connell, J. K. Collins, and F. Shanahan. 1999. Viral load and clinicopathological features of chronic hepatitis C (1b) in a homogeneous patient population. Hepatology 29:904-907.
26. Furtado, M. R., D. S. Callaway, J. P. Phair, K. J. Kunstman, J. L. Stanton, C. A. Macken, A. S. Perelson, and S. M. Wolinsky. 1999. Persistence of HIV-1 transcription in peripheral-blood mononuclear cells in patients receiving potent antiretroviral therapy. N. Engl. J. Med. 340:1614-1622.
27. + T-cell number decline in human immunodeficiency virus type 1-infected individuals. J. Virol. 69:2092-2100.
28. Gabrielli, A., A. Manzin, M. Candela, M. L. Caniglia, S. Paolucci, M. G. Danieli, and M. Clementi. 1994. Active hepatitis C virus infection in bone marrow and peripheral blood mononuclear cells from patients with mixed cryoglohulinemia. Clin. Exp. Immunol. 97:87-93.
29. Galli, M., C. Balotta, L. Meroni, M. C. Colombo, L. Papagno, P. Bagnarelli, L. Testa, S. Varchetta, L. Colombo, M. Moroni, A. d'Arminio Monforte, M. Clerici, and M. Clementi. 1998. Early increase in cell-associated HIV-1 DNA in patients on highly active antiretroviral therapy. AIDS 12:2500-2502.
30. Gallinella, G., M. Zerbini, M. Musiani, S. Venturoli, G. Gentilomi, and E. Manaresi. 1997. Quantitation of parvovirus B19 DNA sequences by competitive PCR: differential hybridization of the amplicons and immunoenzymatic detection on microplate. Mol. Cell. Probes 11:127-133.
31. Gerken, G., J. Gomes, P. Lampertico, M. Colombo, T. Rothaar, M. Trippler, and G. Colucci. 1998. Clinical evaluation and applications of the Amplicor HBV Monitor test, a quantitative HBV DNA PCR assay. J. Virol. Methods 74:155-165.
32. Gerna, G., E. Percivalle, F. Baldanti, A. Sarasini, M. Zavattoni, M. Furione, M. Torsellini, and M. G. Revello. 1998. Diagnostic significance and clinical impact of quantitative assays for diagnosis of human cytomegalovirus infection/disease in immunocompromised patients. New Microbiol. 21: 293-308.
33. Gilliland, G., S. Perrin, K. Blanchard, and H. F. Bunn. 1990. Analysis of cytokine mRNA and DNA: detection and quantitation by competitive polymerase chain reaction. Proc. Natl. Acad. Sci. USA 87:2725-2729.
34. Giostra, F., A. Manzin, M. Lenzi, R. Francesconi, L. Solforosi, P. Manotti, L. Muratori, D. Zauli, M. Clementi, and F. B. Bianchi. 1996. Low hepatitis C viremia levels in patients with anti-liver/kidney microsomal antibody type 1 positive chronic hepatitis. J. Hepatol. 25:433-438.
35. Gupta, P., L. Kingsley, J. Armstrong, M. Ding, M. Cottril, and C. Rinaldo. 1993. Enhanced expression of human immunodeficiency virus type 1 correlated with development of AIDS. Virology 196:586-595
36. Gut, M., C. M. Leutenegger, J. B. Huder, N. C. Pedersen, and H. Lutz. 1999. One-tube fluorogenic reverse transcription-polymerase chain reaction for the quantitation of feline coronaviruses. J. Virol. Methods 77:37-46.
37. Hawrami, K., and J. Breuer. 1999. Development of a fluorogenic polymerase chain reaction assay (TaqMan) for the detection and quantitation of varicella zoster virus. J. Virol. Methods 79:33-40.
38. Hertogs, K., M. P. de Bethune, V. Miller, T. Ivens, P. Schel, A. Van Cauwenberge, C. Van Den Eynde, V. Van Gerwen, H. Azijn, M. Van Houtte, F. Peeters, S. Staszewski, M. Conant, S. Bloor, S. Kemp, B. Larder, and R. Pauwels. 1998. A rapid method for simultaneous detection of phenotypic resistance to inhibitors of protease and reverse transcriptase in recombinant human immunodeficiency virus type 1 isolates from patients treated with antiretroviral drugs. Antimicrob. Agents Chemother. 42:269-276.
39. Ho, D. D., A. U. Neuman, A. S. Perelson, W. Chen, J. M. Leonard, and M. Markowitz. 1995. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature (London) 373:123-126.
40. Hockett, R. D., J. M. Kilby, C. A. Derdeyn, M. S. Saag, M. Sillers, K. Squires, S. Chiz, M. A. Nowak, G. M. Shaw, and R. P. Bucy. 1999. Constant mean viral copy number per infected cell in tissue regardless of high, low, or undetectable plasma HIV RNA. J. Exp. Med. 189:1545-1554.
41. Hsu, E. M., P. J. McNicol, F. B. Guijon, and M. Paraskevas. 1993. Quantification of HPV-16 E6-E7 transcription in cervical intraepithelial neoplasia by reverse transcriptase polymerase chain reaction. Int. J. Cancer 55: 397-401.
42. Jeffery, K. J. M., K. Usuku, S. E. Hall, W. Matsumoto, G. P. Taylor, J. Procter, M. Bunce, G. S. Ogg, K. I. Welsh, J. N. Weber, A. L. Lloyd, M. A. Nowak, M. Nagai, D. Kodama, S. Izumo, M. Osame, and C. R. M. Bangham. 1999. HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I-associated myelopathy. Proc. Natl. Acad. Sci. USA 96:3848-3853.
43. Kawai, S., O. Yokosuka, T. Kanda, F. Imazeki, Y. Maru, and H. Saisho. 1999. Quantification of hepatitis C virus by TaqMan PCR: comparison with HCV Amplicor Monitor assay. J. Med. Virol. 58:121-126.
44. Kogan, D. L., M. Burroughs, S. Emre, T. Fishbein, A. Moscona, C. Ramson, and B. L. Schneider. 1999. Prospective longitudinal analysis of quantitative Epstein-Barr virus polymerase chain reaction in pediatric liver transplant recipients. Transplantation 67:1068-1070.
45. Lam, N. P., A. U. Neumann, D. R. Gretch, T. E. Wiley, A. S. Perelson, and T. J. Layden. 1997. Dose-dependent acute clearance of hepatitis C genotype 1 virus with interferon alfa. Hepatology 26:226-231.
46. Lau, J. Y., G. L. Davis, J. Kniffen, K. P. Qian, M. S. Urdea, C. S. Chan, M. Mizokami, P. D. Neuwald, and J. C. Wilber. 1993. Significance of serum hepatitis C virus RNA levels in chronic hepatitis C. Lancet 341:1501-1504.
47. Lau, J. Y., M. Mizokami, T. Ohno, D. A. Diamond, J. Kniffen, and G. L. Davis. 1993. Discrepancy between biochemical and virological responses to interferon-alpha in chronic hepatitis C. Lancet 342:1208-1209.
48. Leutenegger, C. M., D. Klein, R. Hofmann-Lehmann, C. Mislin, U. Hummel, J. Boni, F. Boretti, W. H. Guenzburg, and H. Lutz. 1999. Rapid feline immunodeficiency virus provirus quantitation by polymerase chain reaction using the TaqMan fluorogenic real-time detection system. J. Virol. Methods 78:105-116.
49. Liuzzi, G., A. Chirianni, M. Clementi, P. Bagnarelli, A. Valenza, P. T. Catalan, and M. Piazza. 1996. Analysis of HIV-1 load in blood, semen and saliva: evidence for different viral compartments in a cross-sectional and longitudinal study. AIDS 10:F51-F56.
50. Lo, Y. M., L. Y. Chan, K. W. Lo, S. F. Leung, J. Zhang, A. T. Chan, J. C. Lee, N. M. Hjelm, P. J. Johnson, and D. P. Huang. 1999 Quantitative analysis of cell-free Epstein-Barr virus DNA in plasma of patients with nasopharyngeal carcinoma. Cancer Res. 59:1188-1191.
51. Manzin, A., P. Bagnarelli, S. Menzo, F. Giostra, M. Brugia, R. Francesconi, F. B. Bianchi, and M. Clementi. 1994. Quantitation of hepatitis C virus genome molecules in plasma samples. J. Clin. Microbiol. 32:1939-1944.
52. Manzin, A., M. Candela, S. Paolucci, M. L. Caniglia, A. Gabrielli, and M. Clementi. 1994. Presence of hepatitis C virus (HCV) genomic RNA and viral replicative intermediates in bone marrow and peripheral blood mononuclear cells from HCV-infected patients. Clin. Diagn. Lab. Immunol. 1:160-163.
53. Manzin, A., M. Candela, L. Solforosi, A. Gabrielli, and M. Clementi. 1999. Dynamics of hepatitis C viremia after plasma exchange. J. Hepatol. 31:389-393.
54. Manzin, A., L. Solforosi, D. Bianchi, A. Gabrielli, F. Giostra, S. Bruno, and M. Clementi. 1995. Virus load in samples from hepatitis C virus (HCV)-infected patients with various clinical conditions. Res. Virol. 146:279-284.
55. Manzin, A., L. Solforosi, M. Candela, G. Cherubini, G. Piccinini, M. Brugia, A. Gabrielli, and M. Clementi. 1996. Hepatitis C virus infection and cryoglobulinemia: assessment of HCV RNA copy numbers in supernatant, cryoprecipitate and non-liver cells. J. Viral Hepatitis 3:285-292.
56. Manzin, A., L. Solforosi, F. Giostra, F. B. Bianchi, S. Bruno, S. Rossi, A. Gabrielli, M. Candela, E. Petrelli, and M. Clementi. 1997. Quantitative analysis of hepatitis C virus activity in different groups of untreated patients. Arch. Virol. 142:465-472.
57. Marschner, I. C. 1998. Design of HIV viral dynamics studies. Stat. Med. 17:2421-2434.
58. Martell, M., J. Gomez, J. I. Esteban, S. Sauleda, J. Quer, B. Cabot, R. Esteban, and J. Guardia. 1999. High-throughput real-time reverse transcription-PCR quantitation of hepatitis C virus RNA. J. Clin. Microbiol. 37:327-332.
59. Mathez, D., P. Bagnarelli, I. Gorin, C. Katlama, G. Pialoux, G. Saimot, P. Tubiana, P. De Truchis, J.-P. Chauvin, R. Mills, R. Rode, M. Clementi, and J. Leibowitch. 1997. Reductions in viral load and increases in T lymphocyte numbers in treatment of naive patients with advanced HIV-1 infection treated with ritonavir, zidovudine and zalcitabine triple therapy. Antivir. Ther. 2:175-183.
60. Mellors, J. W., L. A. Kingsley, C. R. Rinaldo, J. A. Todd, B. S. Hoo, R. P. Kokka, and P. Gupta. 1995. Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion. Ann. Intern. Med. 122:573-579.
61. Mellors, J. W., C. R. Rinaldo, P. Gupta, R. M. White, J. A. Todd, and L. A. Kingsley. 1996. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 272:1167-1170.
62. Menzo, S., P. Bagnarelli, M. Giacca, A. Manzin, P. E. Varaldo, and M. Clementi. 1992. Absolute quantitation of viremia in human immunodeficiency virus infection by competitive reverse transcription polymerase chain reaction. J. Clin. Microbiol. 30:1752-1757.
63. Michael, N. L., M. Vahey, D. S. Burke, and R. R. Redfield. 1992. Viral DNA and mRNA expression correlate with the stage of human immunodeficiency virus (HIV) type 1 infection in humans: evidence for viral replication in all stages of HIV disease. J. Virol. 66:310-316.
64. Morris, T., B. Robertson, and M. Gallagher. 1996. Rapid reverse transcription-PCR detection of hepatitis C virus RNA in serum by using the TaqMan fluorogenic detection system. J. Clin. Microbiol. 34:2933-2936.
65. Neumann, A. U., N. P. Lam, H. Dahari, D. R. Gretch, T. E. Wiley, T. J. Layden, and A. S. Perelson. 1998. Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy. Science 282:103-107.
66. Nolte, F. S. 1998. Branched DNA signal amplification for direct quantitation of nucleic acid sequences in clinical specimens. Adv. Clin. Chem. 33:201-235.
67. Nowak, M. A., S. Bonhoeffer, A. M. Hill, R. Boehme, H. C. Thomas, and H. McDade. 1996. Viral dynamics in hepatitis B virus infection. Proc. Natl. Acad. Sci. USA 93:4398-4402.
68. Oehlenschlager, F., P. Schwille, and M. Eigen. 1996. Detection of HIV-1 RNA by nucleic acid sequence-based amplification combined with fluorescence correlation spectroscopy. Proc. Natl. Acad. Sci. USA 93:12811-12816.
69. Ohsawa, M., N. Shingu, H. Miwa, H. Yoshihara, M. Kubo, H. Tsukuma, H. Teshima, M. Hashimoto, and K. Aozasa. 1999. Risk of non-Hodgkin's lymphoma in patients with hepatitis C virus infection. Int. J. Cancer 80: 237-239.
70. Pantaleo, G., S. Menzo, M. Vaccarezza, C. Graziosi, O. J. Cohen, J. F. Demarest, D. Montefiori, J. M. Orenstein, C. Fox, L. K. Schrager, J. B. Margolik, S. Buchbinder, J. V. Giorgi, and A. S. Fauci. 1995. Studies in subjects with long-term progressive human immunodeficiency virus infection. N. Engl. J. Med. 332:209-216.
71. Pawlotski, J. M., M. Martinot-Peignoux, J. D. Poveda, A. Bastie, V. La Breton, F. Darthuy, J. Remire, S. Erlinger, D. Dhumeaux, and P. Marcellin. 1999. Quantification of hepatitis C virus RNA in serum by branched DNA-based signal amplification assays. J. Virol. Methods 79:227-235.
72. Perelson, A. S., P. Essunger, Y. Cao, M. Vesanen, A. Hurley, K. Saksela, M. Markowitz, and D. D. Ho. 1997. Decay characteristics of HIV-1-infected compartments during combination therapy. Nature (London) 387:188-191.
73. Perelson, A. S., A. U. Neumann, M. Markowitz, J. M. Leonard, and D. D. Ho. 1996. HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time. Science 271:1582-1586.
74. Perno, C.-F., F. M. Newcomb, D. A. Davis, S. Aquaro, R. W. Humphrey, R. Caliò, and R. J. Yarchoan. 1998. Relative potency of protease inhibitors in monocytes/macrophages acutely and chronically infected with human immunodeficiency virus. J. Infect. Dis. 178:413-422.
75. Piatak, M., M. S. Saag, L. C. Yang, S. J. Clark, J. C. Kappes, K.-C. Luk, B. H. Hahn, G. M. Shaw, and J. D. Lifson. 1993. High levels of HIV-1 RNA in plasma during all stages of infection determined by competitive PCR. Science 259:1749-1754.
76. Pistello, M., S. Menzo, M. Giorgi, L. Da Prato, G. Cammarota, M. Clementi, and M. Bendinelli. 1994. Competitive polymerase chain reaction for quantitating feline immunodeficiency virus load in infected cat tissues. Mol. Cell. Probes 8:229-234.
77. Poirier-Toulemonde, A. S., B. M. Imbert-Marcille, V. Ferre-Aubineau, B. Besse, M. G. Le Roux, D. Cantarovich, and S. Billaudel. 1997. Successful quantification of cytomegalovirus DNA by competitive PCR and detection with capillary electrophoresis. Mol. Cell. Probes 11:11-23.
78. Pontisso, P., G. Bellati, M. Brunetto, L. Chemello, G. Colloredo, R. Di Stefano, M. Nicoletti, M. G. Rumi, M. G. Ruvoletto, R. Soffredini, L. M. Valenza, and G. Colucci. 1999. Hepatitis C virus RNA profiles in chronically infected individuals: do they relate to disease activity? Hepatology 29:585-589.
79. Ramakrishnan, R., D. J. Fink, G. Jiang, P. Desai, J. C. Glorioso, and M. Levine. 1994. Competitive quantitative PCR analysis of herpes simplex virus type 1 DNA and latency-associated transcript RNA in latently infected cells of the rat brain. J. Virol. 68:1864-1873.
80. Saiki, R. K., T. L. Bugawan, G. T. Horn, K. B. Mullins, and H. A. Erlich. 1986. Analysis of enzymatically amplified B-globin and HLA-Dqa DNA with allele specific oligonucleotide probes. Nature (London) 324:163-166.
81. Saiki, R. K., D. Gelfand, S. Stoffel, S. J. Scharf, R. Higuel, G. T. Horn, K. B. Mullins, and H. A. Erlich. 1988. Primer directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 239:487-491.
82. Saksela, K., C. Stevens, P. Rubinstein, and D. Baltimore. 1994. Human immunodeficiency virus type 1 mRNA expression in peripheral blood cells predicts disease progression independently of the number of CD4 lymphocytes. Proc. Natl. Acad. Sci. USA 91:1104-1108.
83. Sawtell, N. M., D. K. Poon, C. S. Tansky, and R. L. Thompson. 1998. The latent herpes simplex virus type 1 genome copy number in individual neurons is virus strain specific and correlates with reactivation. J. Virol. 72: 5343-5350.
84. Scadden, D. T., Z. Wang, and J. E. Groopman. 1992. Quantitation of plasma human immunodeficiency virus type 1 RNA by competitive polymerase chain reaction. J. Infect. Dis. 165:1119-1123.
85. Schmit, J.-C., and B. Weber. 1997. Recent advances in antiretroviral therapy and HIV infection monitoring. Intervirology 40:304-321.
86. Slobedman, B., and E. S. Mocarski. 1999. Quantitative analysis of latent human cytomegalovirus. J. Virol. 73:4806-4812.
87. Spector, S. A., R. Wong, K. Hsia, M. Pilcher, and M. J. Stempien. 1998. Plasma cytomegalovirus (CMV) DNA load predicts CMV disease and survival in AIDS patients. J. Clin. Investig. 101:497-502.
88. Stevens, S. J., M. B. Vervoort, A. J. van den Brule, P. L. Meenhorst, C. J. Meyer, and J. M. Middeldorp. 1999. Monitoring of Epstein-Barr virus load in peripheral blood by quantitative competitive PCR. J. Clin. Microbiol. 37:2852-2857.
89. Swan, D. C., R. A. Tucker, G. Tortolero-Luna, M. F. Mitchell, L. Wideroff, E. R. Unger, R. A. Nisenbaum, W. C. Reeves, and J. P. Icenogle. 1999. Human papillomavirus (HPV) DNA copy number is dependent on grade of cervical disease and HPV type. J. Clin. Microbiol. 37:1030-1034.
90. Trabaud, M. A., F. Bailly, S. N. Si-Ahmed, P. Chevallier, M. Sepetjan, G. Colucci, and C. Trepo. 1997. Comparison of HCV RNA assays for the detection and quantification of hepatitis C virus RNA levels in serum of patients with chronic hepatitis C treated with interferon. J. Med. Virol. 52:105-112.
91. Tsai, W. P., S. R. Conley, H. F. Kung, R. R. Garrity, and P. L. Nara. 1996. Preliminary in vitro growth cycle and transmission studies of HIV-1 in an autologous primary cell assay of blood-derived macrophages and peripheral blood mononuclear cells. Virology 26:205-216.
92. Vener, T., M. Nygren, A. Andersson, M. Uhlen, J. Albert, and J. Lundeberg. 1998. Use of multiple competitors for quantification of human immunodeficiency virus type 1 RNA in plasma. J. Clin. Microbiol. 36:1864-1870.
93. Vernazza, P. L., J. J. Eron, M. S. Cohen, C. M. van der Horst, L. Troiani, and S. A. Fiscus. 1994. Detection and biologic characterization of infectious HIV-1 in semen of seropositive men. AIDS 8:1325-1329.
94. Wang, K., L. Pesnicak, and S. E. Strauss. 1997. Mutations in the 5′ end of the herpes simplex virus type 2 latency-associated transcript (LAT) promoter affect LAT expression in vivo but not the rate of spontaneous reactivation of genital herpes. J. Virol. 71:7903-7910.
95. Wel, X., S. K. Gosh, M. E. Taylor, V. A. Johnson, E. A. Emini, P. Deutsch, J. D. Lifson, S. Bonhoefer, M. A. Nowak, B. H. Hahn, M. S. Saag, and G. M. Shaw. 1995. Viral dynamics in human immunodeficiency virus type 1 infection. Nature (London) 373:117-122.
96. Wodarz, D., A. L. Lloyd, V. A. Jansen, and M. A. Nowak. 1999. Dynamics of macrophage and T cell infection by HIV. J. Theor. Biol. 196:101-113.
97. Wu, H., A. A. Ding, and V. De Gruttola. 1998. Estimation of HIV dynamic parameters. Stat. Med. 17:2463-2485.
98. Zeuzem, S., A. Franke, J. H. Lee, G. Hermann, B. Ruster, and W. K. Roth. 1996. Phylogenetic analysis of hepatitis C virus isolates and their correlation to viremia, liver function tests, and histology. Hepatology 24:1003-1009.
99. Zhang, L., B. Ramratnam, K. Tenner-Racz, Y. He, M. Vesanen, S. Lewin, A. Talal, P. Racz, A. S. Perelson, B. T. Korber, M. Markowitz, and D. D. Ho. 1999. Quantifying residual HIV-1 replication in patients receiving combination antiretroviral therapy. N. Engl. J. Med. 340:1605-1613.
100. Zhu, T., N. Wang, A. Carr, D. S. Nam, R. Moor-Jankowski, D. A. Cooper, and D. D. Ho. 1996. Genetic characterization of human immunodeficiency virus type 1 in blood and genital secretions: evidence for viral compartmentalization and selection during sexual transmission. J. Virol. 70:3098-3107.
101. Zhender, G., L. Meroni, C. De Maddalena, S. Varchetta, G. Monti, and M. Galli. 1997. Detection of hepatitis C virus RNA in CD19 peripheral blood mononuclear cells of chronically infected patients. J. Infect. Dis. 176:1209-1214.
102. Zignego, A. L., D. Macchia, M. Monti, V. Thiers, M. Mazzetti, M. Foschi, E. Maggi, S. Romagnani, P. Gentilini, and C. Brechot. 1992. Infection of peripheral mononuclear blood cells by hepatitis C virus. J. Hepatol. 15: 382-386.